Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma von Shafer, Danielle, Tombes, Mary Beth, Shrader, Ellen, Ryan, Alison, Bandyopadhyay, Dipankar, Dent, Paul, Malkin, Mark

Volltext

Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies von Shafer, Danielle, Kagan, Amanda B., Rudek, Michelle A., Kmieciak, Maciej, Tombes, Mary Beth, Shrader, Ellen, Bandyopadhyay, Dipankar, Hudson, Daniel, Sankala, Heidi, Weir, Caryn, Lancet, Jeffrey E., Grant, Steven

Volltext

Phase I study of regorafenib and sildenafil in advanced solid tumors von Poklepovic, Andrew Stewart, Gordon, Sarah W., McGuire, William P., Thacker, Leroy R., Deng, Xiaoyan, Tombes, Mary Beth, Shrader, Ellen, Ryan, Alison A., Kmieciak, Maciej, Dent, Paul

Volltext

A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma von Holkova, Beata, Zingone, Adriana, Kmieciak, Maciej, Bose, Prithviraj, Badros, Ashraf Z, Voorhees, Peter M, Baz, Rachid, Korde, Neha, Lin, Hui-Yi, Chen, Jin-Qiu, Herrmann, Michelle, Xi, Liqiang, Raffeld, Mark, Zhao, Xiuhua, Wan, Wen, Tombes, Mary Beth, Shrader, Ellen, Weir-Wiggins, Caryn, Sankala, Heidi, Hogan, Kevin T, Doyle, Austin, Annunziata, Christina M, Wellons, Martha, Roberts, John D, Sullivan, Daniel, Landgren, Ola, Grant, Steven

Volltext

Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma multiforme von Shafer, Danielle A., Chen, Zhi-jian, Harris, Timothy, Tombes, Mary Beth, Shrader, Ellen, Strickler, Kathryn, Ryan, Alison A., Dent, Paul, Malkin, Mark Gordon

Volltext

A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma von Yazbeck, Victor, Shafer, Danielle, Perkins, Edward B., Coppola, Domenico, Sokol, Lubomir, Richards, Kristy L., Shea, Thomas, Ruan, Jia, Parekh, Samir, Strair, Roger, Flowers, Christopher, Morgan, David, Kmieciak, Maciej, Bose, Prithviraj, Kimball, Amy, Badros, Ashraf Z., Baz, Rachid, Lin, Hui-Yi, Zhao, Xiuhua, Reich, Richard R., Tombes, Mary Beth, Shrader, Ellen, Sankala, Heidi, Roberts, John D., Sullivan, Daniel, Grant, Steven, Holkova, Beata

Volltext

A Phase I Trial of Vorinostat and Alvocidib in Patients with Relapsed, Refractory, or Poor Prognosis Acute Leukemia, or Refractory Anemia with Excess Blasts-2 von HOLKOVA, Beata, SUPKO, Jeffrey G, KMIECIAK, Maciej, SHRADER, Ellen, WELLONS, Martha D, SANKALA, Heidi, DOYLE, Austin, WRIGHT, John, ROBERTS, John D, GRANT, Steven, AMES, Matthew M, REID, Joel M, SHAPIRO, Geoffrey I, PERKINS, Edward Brent, RAMAKRISHNAN, Viswanathan, TOMBES, Mary Beth, HONEYCUTT, Connie, MCGOVERN, Renee M

Volltext

Phase I study of pemetrexed and sorafenib in advanced solid tumors von Poklepovic, Andrew Stewart, Shafer, Danielle A., Roberts, John D., Geyer, Charles E., Dent, Paul, Moran, Richard, Tombes, Mary Beth, Shrader, Ellen, Strickler, Kathryn, Wan, Wen

Volltext

Phase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent... von Holkova, Beata, Kmieciak, Maciej, Perkins, E Brent, Bose, Prithviraj, Baz, Rachid C, Roodman, G David, Stuart, Robert K, Ramakrishnan, Viswanathan, Wan, Wen, Peer, Cody J, Dawson, Jana, Kang, Loveleen, Honeycutt, Connie, Tombes, Mary Beth, Shrader, Ellen, Weir-Wiggins, Caryn, Wellons, Martha, Sankala, Heidi, Hogan, Kevin T, Colevas, A Dimitrios, Doyle, L Austin, Figg, William D, Coppola, Domenico, Roberts, John D, Sullivan, Daniel, Grant, Steven

Volltext

Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory B-Cell Neoplasms von HOLKOVA, Beata, PERKINS, E. Brent, KANG, Loveleen, DAWSON, Jana, STUART, Robert K, PEER, Cody, FIGG, William D, KOLLA, Sarah, DOYLE, Austin, WRIGHT, John, SULLIVAN, Daniel M, ROBERTS, John D, RAMAKRISHNAN, Viswanathan, GRANT, Steven, TOMBES, Mary Beth, SHRADER, Ellen, TALREJA, Neha, WELLONS, Martha D, HOGAN, Kevin T, ROODMAN, G. David, COPPOLA, Domenico

Volltext

Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, Peripheral T-Cell Lymphoma, or Cutane... von Holkova, Beata, Kmieciak, Maciej, Bose, Prithviraj, Ma, Shuo, Kimball, Amy, Tombes, Mary Beth, Shrader, Ellen, Wan, Wen, Weir-Wiggins, Caryn, Stoddert, Elizabeth, Singh, Amanda Garnett, Dean, April, Conine, Sarah, Sankala, Heidi, Roberts, John D., Shea, Thomas C., Grant, Steven

Volltext

A Phase 2 Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma von Holkova, Beata, Zingone, Adriana, Kmieciak, Maciej, Bose, Prithviraj, Badros, Ashraf Z., Voorhees, Peter M., Baz, Rachid, Korde, Neha, Lin, Hui-Yi, Chen, Jin-Qiu, Herrmann, Michelle, Xi, Liqiang, Raffeld, Mark, Zhao, Xiuhua, Wan, Wen, Tombes, Mary Beth, Shrader, Ellen, Weir-Wiggins, Caryn, Sankala, Heidi, Hogan, Kevin T., Doyle, Austin, Annunziata, Christina M., Wellons, Martha, Roberts, John D., Sullivan, Daniel, Landgren, Ola, Grant, Steven

Volltext

Phase I study of pemetrexed with sorafenib in advanced solid tumors von Poklepovic, Andrew, Gordon, Sarah, Shafer, Danielle A, Roberts, John D, Bose, Prithviraj, Geyer, Jr, Charles E, McGuire, William P, Tombes, Mary Beth, Shrader, Ellen, Strickler, Katie, Quigley, Maria, Wan, Wen, Kmieciak, Maciej, Massey, H Davis, Booth, Laurence, Moran, Richard G, Dent, Paul

Volltext

Phase I Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, or Peripheral T-Cell Lymphoma von Holkova, Beata, Shea, Thomas C., Bose, Prithviraj, Tombes, Mary Beth, Shrader, Ellen, Wan, Wen, Weir-Wiggins, Caryn, Stoddert, Elizabeth, Sankala, Heidi, Kmieciak, Maciej, Roberts, John D., Grant, Steven

Volltext

Phase I Trial of Belinostat and Bortezomib in Patients with Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia in Blast Crisis - One Y... von Holkova, Beata, Bose, Prithviraj, Tombes, Mary Beth, Shrader, Ellen, Wan, Wen, Weir-Wiggins, Caryn, Stoddert, Elizabeth, Sankala, Heidi, Kmieciak, Maciej, Roberts, John D., Garcia-Manero, Guillermo, Grant, Steven

Volltext

Phase I Trial Of Carfilzomib In Combination With Vorinostat (SAHA) In Patients With Relapsed/Refractory B-Cell Lymphomas von Holkova, Beata, Kmieciak, Maciej, Bose, Prithviraj, Barr, Paul M., Tombes, Mary Beth, Shrader, Ellen, Cebula, Erin, Pierce, Emily, Herr, Megan M., Sankala, Heidi, Feng, Changyong, Fisher, Richard I, Grant, Steven, Friedberg, Jonathan W.

Volltext

Phase I Trial of Bortezomib (PS-341; NSC 681239) and “Non-Hybrid “(Bolus) Infusion Schedule of Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory Indolen... von Holkova, Beata, Kmieciak, Maciej, Perkins, E. Brent, Bose, Prithviraj, Baz, Rachid C., Roodman, G. David, Stuart, Robert K., Ramakrishnan, Viswanathan, Wan, Wen, Peer, Cody J, Dawson, Jana, Kang, Loveleen, Honeycutt, Connie, Tombes, Mary Beth, Shrader, Ellen, Weir-Wiggins, Caryn, Wellons, Martha, Sankala, Heidi, Hogan, Kevin T., Colevas, A. Dimitrios, Doyle, L. Austin, Figg, William D., Coppola, Domenico, Roberts, John D., Sullivan, Daniel, Grant, Steven

Volltext

Phase I Trial of Belinostat and Bortezomib in Patients with Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia in Blast Crisis von Holkova, Beata, Tombes, Mary Beth, Shrader, Ellen, Cooke, Sheryl S., Wan, Wen, Sankala, Heidi, Kmieciak, Maciej, Roberts, John D., Garcia-Manero, Guillermo, Grant, Steven

Volltext

Phase I Trial of Bortezomib (PS-341; NSC 681239) and Alvocidib (Flavopiridol; NSC 649890) in Patients with Recurrent or Refractory Indolent B-Cell Neoplasms - Update of the “Bolus”... von Holkova, Beata, Perkins, Edward B., Bose, Prithviraj, Sullivan, Daniel M, Baz, Rachid, Tombes, Mary Beth, Shrader, Ellen, Ramakrishnan, Viswanathan, Wan, Wen, Sankala, Heidi, Kmieciak, Maciej, Roberts, John D., Grant, Steven

Volltext

A Phase II Study of the MEK 1/2 Inhibitor AZD6244 (Selumetinib, ARRY-142866) in Relapsed or Refractory Multiple Myeloma von Holkova, Beata, Badros, Ashraf Z., Geller, Robert, Voorhees, Peter M., Zingone, Adriana, Korde, Neha, Lin, Hui-Yi, Tombes, Mary Beth, Shrader, Ellen, Sankala, Heidi, Kmieciak, Maciej, Roberts, John D., Sullivan, Daniel, Landgren, Ola, Grant, Steven

Volltext